For the Quarter Ending September 2025
North America
• In North America, the Resorcinol Price Index fell by ~5.5% quarter-over-quarter amid elevated importer/distributor stocks and muted industrial orders.
• The average Resorcinol price for the quarter was approximately USD 4,900/MT.
• Resorcinol Spot Price tightened briefly in late August as downstream processors pulled forward volumes, then eased in September as inventories were rebuilt.
• Resorcinol Price Forecast points to cautious recovery into Q4 as formulation and pharmaceutical buyers resume seasonal procurement.
• Resorcinol Production Cost Trend remained steady, though inland freight and packaging costs edged up marginally.
• Resorcinol Demand Outlook improved modestly from personal care and pharma segments, while larger industrial users remained conservative.
• Price Index volatility was noticeable around port congestion and routing delays, though overall supply remained adequate.
• Logistics showed intermittent congestion at key ports but no systemic disruptions.
Why did the price of Resorcinol change in September 2025 in North America?
• Elevated importer and distributor inventories reduced immediate purchase urgency.
• Short-term upstream offtake from personal care and pharma tightened availability, causing spot swings.
• Inland freight and packaging cost increases set a floor under price declines.
• Anticipation of Q4 restocking supported buying interest, preventing deeper falls.
APAC
• In Japan, the Resorcinol Price Index fell by 3.42% quarter-over-quarter, subdued export buying and high inventories.
• The average Resorcinol price for the quarter was approximately USD 4846.67/MT, reflecting subdued export and steady domestic procurement.
• Resorcinol Spot Price tightened in August before easing in September, reflecting stronger domestic offtake and constrained buffers.
• Resorcinol Price Forecast indicates modest firming as replenishment demand meets slowly normalizing inventories and steady export allocations.
• Resorcinol Production Cost Trend remained stable supported by consistent benzene availability, limiting upstream inflationary pressure.
• Resorcinol Demand Outlook improved with personal care and pharmaceutical procurement resuming, boosting near-term consumption and order confirmation rates.
• Resorcinol Price Index volatility reflected inventory cycles, buyer front-loading in May, subsequent pullback, then renewed offtake ahead of Q4.
• Market participants reported smooth logistics and port operations, which prevented supply disruptions while maintaining transactional confidence and delivery reliability.
Why did the price of Resorcinol change in September 2025 in APAC?
• Domestic downstream offtake increased, tightening availability against steady exports and reducing immediate buffer inventories thereby.
• Buyers delayed purchases earlier in quarter, creating oversupply then rapid replenishment demand drove price recovery dynamics.
• Stable benzene feedstock and uninterrupted logistics limited cost pressures, so demand-side dynamics primarily drove the September Price Index movement.
Europe
• In key EU markets, the Resorcinol Price Index fell by ~4.0% quarter-over-quarter, driven by soft export inquiries and inventory digestion across chemical distributors.
• The average Resorcinol price for the quarter was approximately USD 5,050/MT.
• Resorcinol Spot Price softened through September after a brief tightening in August as distributors released stocks to meet inland demand.
• Resorcinol Price Forecast indicates mild firming into Q4 as replenishment by adhesives and rubber chemical segments increases.
• Resorcinol Production Cost Trend was stable to mildly higher due to elevated energy and storage costs in late summer.
• Resorcinol Demand Outlook showed gradual improvement from personal care and specialty chemical users, offsetting weaker industrial buying.
• Resorcinol Price Index volatility was moderate — seasonal buying and currency fluctuations (EUR/USD) added short-term noise.
• Market logistics remained largely smooth, with port throughput and inland transport operating without major disruption.
Why did the price of Resorcinol change in September 2025 in Europe?
• Distributor inventory digestion after earlier front-loading reduced immediate buying.
• Renewed offtake from adhesives and specialty chemical processors tightened spot availability.
• Energy and storage cost pressures limited how far prices could fall, supporting bids.
• Currency movements and steady logistics moderated landed-cost swings, keeping volatility contained.
For the Quarter Ending June 2025
Asia Pacific
• Resorcinol Spot Price in Asia Pacific experienced a sharp downward trend in Q2 2025 with June closing at USD 4675/MT FOB Tokyo. It marked a decline of 2.71% and was driven by limited transactional volumes.
• Bulk orders and anti-dumping probe enquiry in India executed a significant 13.81% price drop in May. It left buyers overstocked which resulted in weak fresh demand in June.
• Resorcinol Production Cost Trend remained stable throughout the quarter, supported by smooth benzene supply and efficient plant operations without outages.
• Export volumes remained steady, but oversupply conditions stemming from earlier front-loaded procurement continued to suppress market pricing.
• Domestic pharmaceutical demand in Japan held steady for dermatological, antiseptic, and analgesic applications, but international offtake declined.
• Inventories remained elevated due to May’s aggressive buying behaviour, leaving sellers unable to support prices amid soft international demand.
• Operational continuity and uninterrupted logistics ensured no supply-side disruptions, further keeping prices under pressure.
• Resorcinol Demand Outlook for Q2 was muted as seasonal demand remained absent and downstream industries postponed orders into Q3.
• Why did the price change in July 2025?
A marginal uptick was observed due to slight restocking by excipient formulators and regional traders anticipating Q3 procurement cycles.
• Resorcinol Price Forecast for early Q3 remains conservative, with expectations of mild recovery driven by gradual inventory drawdown and seasonal formulation activity.
North America
• Resorcinol Spot Price in North America showed a generally weak trajectory through Q2 2025, influenced by sluggish downstream activity across adhesives and specialty chemicals.
• Market sentiment remained bearish, with end-users refraining from long-term commitments amid economic caution and soft industrial output.
• Inventory levels across distributors stayed high, echoing the oversupply trend seen in APAC, as buyers relied on earlier procurement.
• The Resorcinol Production Cost Trend remained steady, aided by falling feedstock prices and balanced operating rates at domestic facilities.
• Import pressure from Asia Pacific, particularly Japan, added competitive pricing pressure due to cheaper export offers.
• The sector witnessed no major logistical disruptions, maintaining consistent supply chains throughout Q2.
• Domestic demand remained range-bound, with little variation in requirement from pharmaceutical and industrial adhesive manufacturers.
• Resorcinol Demand Outlook remained weak but stable; most buyers awaited Q3 price signals before engaging in new volume commitments.
• Why did the price change in July 2025?
North America saw a marginal price uptick as buyers initiated moderate restocking amidst steady offshore shipments and forecasts of limited Q3 availability.
• Resorcinol Price Forecast for Q3 suggests a cautious rise driven by tight inventories and slight pickup in industrial activity.
Europe
• Resorcinol Spot Price in Europe maintained a declining trajectory throughout Q2 2025 due to poor demand from coatings, rubber, and pharma intermediate sectors.
• High stock levels across EU-based buyers, coupled with weak production activity, curbed transactional interest.
• European markets mirrored APAC's sentiment, absorbing cheaper Asian-origin Resorcinol which suppressed regional prices.
• The Resorcinol Production Cost Trend was marginally bearish due to softened benzene costs and weak utility-driven manufacturing expenses.
• Port operations and intra-European transport systems remained fully operational, adding no supply-side risk to prices.
• Buyers took a cautious stance amid ongoing economic uncertainties and lower-than-expected formulation demand in Q2.
• Regional producers refrained from aggressive production expansions due to existing inventory saturation.
• Resorcinol Demand Outlook was subdued, particularly in the specialty pharma and adhesives industries, which slowed procurement cycles.
• Why did the price change in July 2025?
Spot prices ticked upward as inventories began normalizing, and buyers prepared for a potential Q3 formulation rebound.
• Resorcinol Price Forecast for Q3 indicates gradual firming, contingent upon the rebound of industrial activity and sustained inventory discipline across Europe.
For the Quarter Ending March 2025
North America
In North America, the Resorcinol market followed a firm and steady trend during the first quarter of 2025. Prices in the region registered a modest upward movement reflected a steady and slightly firm market trend. This trend aligned with the overall global market situation, especially influenced by developments in the Asia Pacific region.
India’s decision to impose an anti-dumping probe created uncertainty in global supply chains indirectly affecting North American markets. Buyers in the region responded by securing inventories early and adopting a cautious procurement approach. This helped maintain consistent availability in the market. Seasonal transitions from winter to early summer improved logistics and trade activities, supporting smooth supply operations.
Downstream demand from pharmaceuticals, personal care, and food sectors stayed steady, offering reliable consumption. Although tariff discussions surfaced during the quarter, no major disruption occurred. Market participants remained attentive to international supply risks and adjusted stock positions accordingly. By the end of the first quarter of 2025, the Resorcinol market in North America maintained a steady to firm position, supported by balanced demand and secure inventory levels.
Asia Pacific
The Resorcinol market in the Asia Pacific region recorded a notable increase in prices during the first quarter of 2025. The quarterly average price rose by 14.21%, driven by multiple market factors. One of the key reasons behind this sharp incline was India’s decision to launch an anti-dumping investigation on Resorcinol imports. This move created concerns among exporting countries within the region and resulted in changes in supply chain activity.
Procurement strategies became cautious with many buyers trying to secure stocks in advance. As a result, demand from downstream industries such as pharmaceuticals, personal care and food sectors remained firm. The seasonal transition from winter to early summer also encouraged a steady movement of goods.
Additionally, the Chinese Lunar New Year fell in the first quarter which temporarily affected the supply patterns and adding to market pressure. Smooth logistics resumed after the holidays, but prices stayed high due to tight inventories. Overall, the Asia Pacific market remained active and bullish throughout the first quarter of 2025.
Europe
The Resorcinol market in Europe followed a steady to firm pricing trend throughout the first quarter of 2025. Prices remained largely stable during the period, with a slight upward movement observed in certain parts of the market. This trend was influenced by global market movements, particularly the price surge observed in the Asia Pacific region.
India’s anti-dumping probe on Resorcinol affected the wider global market and raised concerns about future supply volumes. European buyers adopted careful procurement strategies and avoided overstocking but ensured enough inventory to manage regular demand. Downstream sectors- including pharmaceuticals, nutraceuticals, personal care and food industries maintained steady consumption levels and provided consistent offtake for suppliers.
Seasonal transition during the first quarter contributed to smooth logistics and uninterrupted trade flows. Though no major price shocks occurred, the market sentiment stayed firm due to anticipation of potential supply tightening in upcoming months. Procurement activities remained strategic throughout the quarter. By the end of the first quarter of 2025, the European Resorcinol market demonstrated stability with a cautiously firm undertone driven by balanced demand and careful inventory management.
For the Quarter Ending December 2024
North America
In Q4 2024, the U.S. Resorcinol market saw a steady rise in prices, fueled by high demand and severe supply chain challenges. In October, strong demand from the food and beverage sector, along with rising import costs from Asia, pushed prices higher. Supply constraints worsened due to increased fuel prices, port congestion, labor strikes, and limited domestic production. Traders' stockpiling in anticipation of winter demand further tightened supply, while higher Sulfuric acid costs raised production expenses.
November continued the upward trend, as skyrocketing Chinese export prices, fluctuating currency rates, and ongoing shipping disruptions added pressure. With limited shipping capacity and rising freight costs, importers faced mounting procurement expenses. Despite strong export demand for U.S.-made Resorcinol, domestic supply shortages left traders with little bargaining power.
These combined factors point to a structural shift in the market, with prices likely to remain elevated unless domestic production ramps up or import sources diversify. Overall, Q4 2024 was characterized by a consistent upward price trend, driven by supply chain disruptions and strong demand.
Asia
The overall trend in Q4 2024 for Resorcinol prices in Japan was a significant upward trajectory, marked by a strong seller's market and supply chain disruptions. In October, limited availability, high demand from the pharmaceutical sector, and rising costs of key raw materials like Sulfuric Acid caused Resorcinol prices to surge.
By November, the market remained bullish, driven by strong demand from Western markets and tight supply, exacerbated by logistical challenges. December saw a critical market shift, with manufacturers leveraging low inventories and post-holiday demand to reset pricing mechanisms, positioning the market for sustained volatility.
Sulfuric Acid prices also rose, supported by increased demand from the agrochemical sector during the plantation season and higher feedstock costs. Despite stable Benzene prices, the overall market sentiment was bullish, reflecting tightening supply conditions. As Japan navigates transportation bottlenecks and strategic production throttling, the Q4 market dynamics signal a broader transformation, with long-term implications for global trade and pricing structures. Market participants must brace for ongoing price volatility in the months ahead.
Europe
In Q4 2024, the European Resorcinol market was marked by significant volatility, driven by rising prices and a series of challenges. The growing reliance on Chinese imports, escalating freight costs, and shifting energy prices created a turbulent market environment. These conditions required traders to adopt more sophisticated inventory and procurement strategies.
Despite these pressures, the food additives and pharmaceuticals sectors showed steady growth, managing increasing operational costs amid uncertain demand. Mid-quarter, opportunities arose as Chinese suppliers cleared their inventories with competitive pricing, which traders were quick to leverage. However, tight regulatory standards and quality control demands added further complexity, making it essential for businesses to stay proactive and adaptable.
The quarter emphasized the need for strategic planning, as European traders balanced cost management with fluctuating demand. It also showcased the market's ability to adapt, utilizing both resilience and forward-thinking strategies to navigate volatility while capitalizing on short-term pricing opportunities.
